Today: 24 June 2026
Browse Category

Stock Market 17 December 2025

Phillips 66 Stock (PSX) Slides on December 17, 2025: What’s Driving the Drop, 2026 Capex Plans, and the Latest Analyst Forecasts

Phillips 66 Stock (PSX) Slides on December 17, 2025: What’s Driving the Drop, 2026 Capex Plans, and the Latest Analyst Forecasts

Phillips 66 shares fell 6.9% to $131.78 on December 17, 2025, following a broad energy sector decline as oil prices hit near five-year lows and U.S. unemployment rose to 4.6%. The company also announced a $2.4 billion capital budget for 2026, slightly above 2025 levels, with increased spending on midstream and refining projects.
17 December 2025
··
Barclays PLC (BARC) News Today (17 December 2025): Share Buyback Update, New Block Listing, Saudi Arabia Push, and Fresh UK Spending Signals

Barclays PLC (BARC) News Today (17 December 2025): Share Buyback Update, New Block Listing, Saudi Arabia Push, and Fresh UK Spending Signals

Barclays on Wednesday filed for a 20 million-share block listing for employee plans and reported buying 2.2 million shares for cancellation under its ongoing buyback. Shares traded near a 52-week high, up over 2% at around 460.60p. The bank also signaled increased investment-banking activity in Saudi Arabia and noted shifting UK consumer spending trends.
17 December 2025
··
ICICI Prudential AMC IPO Allotment Today: How to Check Status on BSE, NSE & KFin, GMP Signals 16–17% Listing Pop, PL Capital Sets ₹3,000 Target

ICICI Prudential AMC IPO Allotment Today: How to Check Status on BSE, NSE & KFin, GMP Signals 16–17% Listing Pop, PL Capital Sets ₹3,000 Target

ICICI Prudential AMC’s ₹10,602.65 crore IPO saw bids totaling about ₹3 trillion, making it one of India’s most subscribed issues, according to Reuters. Share allotment status is expected to be available by late December 17, with listing set for December 19 on BSE and NSE. PL Capital has set a target price of ₹3,000 with a ‘Buy’ rating.
17 December 2025
·
Rezolve AI PLC (NASDAQ: RZLV) Stock News Today: $200M+ ARR Update Sparks Rally — Forecasts, Analyst Targets, and Key Risks (Dec. 17, 2025)

Rezolve AI PLC (NASDAQ: RZLV) Stock News Today: $200M+ ARR Update Sparks Rally — Forecasts, Analyst Targets, and Key Risks (Dec. 17, 2025)

Rezolve AI PLC expects December 2025 revenue to top $17 million and projects year-end annual recurring revenue above $200 million, according to a December 16 update. The company also anticipates positive adjusted EBITDA for the first time. Shares surged to $2.97, with trading and options volume spiking after the news.
17 December 2025
····
Coupang (CPNG) Stock News Today: Parliamentary Fallout, SEC Cyber Filing, and Fresh Wall Street Forecasts (Dec. 17, 2025)

Coupang (CPNG) Stock News Today: Parliamentary Fallout, SEC Cyber Filing, and Fresh Wall Street Forecasts (Dec. 17, 2025)

Coupang shares traded at $23.19 on Dec. 17, down about 17% since disclosing a data breach in late November. South Korean lawmakers escalated pressure at a parliamentary hearing, criticizing CEO Bom Kim’s absence and threatening legal action. Coupang’s SEC filing said a former employee may have accessed data on up to 33 million customer accounts.
17 December 2025
·
Diageo Shares Jump After $2.3bn Asahi Deal: Guinness Owner Sells East African Breweries Stake as Turnaround Debate Intensifies

Diageo Shares Jump After $2.3bn Asahi Deal: Guinness Owner Sells East African Breweries Stake as Turnaround Debate Intensifies

Diageo agreed to sell its 65% stake in East African Breweries to Asahi Group for about $2.3 billion, with completion expected in the second half of 2026. The deal values EABL at $4.8 billion. Diageo shares rose to around 1,720p in London after the announcement but remain far below their 2022 peak of over 4,000p. Diageo will keep a regional presence through licensing agreements.
17 December 2025
···
Pfizer Stock (NYSE: PFE) News Today: 2026 Guidance, Earnings Forecasts, Analyst Price Targets and Key Catalysts

Pfizer Stock (NYSE: PFE) News Today: 2026 Guidance, Earnings Forecasts, Analyst Price Targets and Key Catalysts

Pfizer shares fell 3.4% to $25.53 late Dec. 16 after the company issued 2026 guidance projecting flat-to-declining revenue and adjusted EPS of $2.80–$3.00. The outlook cited lower COVID product sales and a $1.5 billion hit from patent expirations. Pfizer expects no share buybacks through 2026. Wall Street noted the EPS target is slightly below consensus.
17 December 2025
····
Tesla Stock (TSLA) Hits Record High Near $490 as Robotaxi Testing Accelerates — California Autopilot Deadline, Analyst Forecasts, and Key Risks in Focus

Tesla Stock (TSLA) Hits Record High Near $490 as Robotaxi Testing Accelerates — California Autopilot Deadline, Analyst Forecasts, and Key Risks in Focus

Tesla shares are trading near $489.88 after closing at a record high, ending a year-long streak without new peaks. The rally follows news of driverless robotaxi testing, a regulatory reprieve in California, and continued investment in EV supply chains. Elon Musk said Tesla is now testing robotaxis without safety monitors. Investors are comparing Tesla’s progress to Waymo, which leads in commercial robotaxi deployment.
17 December 2025
···
Tilray Brands (TLRY) Stock News Today: Trump Cannabis Rescheduling Reports Fuel Volatility, Fresh Forecasts and Key Levels (Dec. 17, 2025)

Tilray Brands (TLRY) Stock News Today: Trump Cannabis Rescheduling Reports Fuel Volatility, Fresh Forecasts and Key Levels (Dec. 17, 2025)

Tilray Brands shares jumped 27% to $13.94 on December 17, 2025, amid reports President Donald Trump may soon sign an executive order to reclassify marijuana at the federal level. The stock swung between $10.32 and $14.54 during the session. Reuters and NBC News cited sources saying the move could come this week. No final decision has been made, according to a White House spokesperson.
17 December 2025
···
British American Tobacco (BATS.L / BTI) Stock: Today’s Buyback Update, Dividend Dates, and 2026 Outlook (Dec. 17, 2025)

British American Tobacco (BATS.L / BTI) Stock: Today’s Buyback Update, Dividend Dates, and 2026 Outlook (Dec. 17, 2025)

British American Tobacco repurchased 145,000 shares on Dec. 16 at a volume-weighted average price of 4,297.83p, according to a London filing. Shares traded near 4,283p on Dec. 17, close to multi-year highs. BAT also disclosed Non-Executive Director Karen Guerra’s appointment to the board of Société BIC S.A.
17 December 2025
···
Diageo (DGE.L) Stock News Today: Guinness Maker Strikes $2.3bn Asahi Deal — What It Means for Diageo Shares on 17 December 2025

Diageo (DGE.L) Stock News Today: Guinness Maker Strikes $2.3bn Asahi Deal — What It Means for Diageo Shares on 17 December 2025

Diageo agreed to sell its 65% stake in East African Breweries to Japan’s Asahi for $2.3 billion in net proceeds. The deal, expected to close in the second half of 2026, will reduce Diageo’s leverage and includes long-term licensing for Guinness and other brands in the region. Diageo shares traded at 1,684.5 in London on December 17, up slightly from the previous close.
17 December 2025
··
Unilever PLC Stock (UL/ULVR): Today’s News, Analyst Forecasts, and What the Magnum Spin-Off Changes for 2026

Unilever PLC Stock (UL/ULVR): Today’s News, Analyst Forecasts, and What the Magnum Spin-Off Changes for 2026

Unilever shares fell 1.06% to £47.94 in London on December 17, underperforming the FTSE 100, after the company completed the spin-off of its ice cream business as The Magnum Ice Cream Company. Unilever also consolidated shares at an 8-for-9 ratio and canceled over 51 million treasury shares. Analyst revisions point to slower growth expectations post-separation.
17 December 2025
···
Lloyds Banking Group (LLOY) Share Price Today: Stock News, Analyst Forecasts and Key Risks as of 17 December 2025

Lloyds Banking Group (LLOY) Share Price Today: Stock News, Analyst Forecasts and Key Risks as of 17 December 2025

Lloyds Banking Group closed at 95.80p on 17 December 2025, up 0.78%, with a market value near £56.26bn. The stock has risen 71.6% over the past year, trading just below its 52-week high. Lloyds is working with the FCA on agentic AI trials set for early 2026, while facing ongoing risk from the UK motor finance redress, which could cost the industry up to £20bn.
17 December 2025
·
NatWest Group Plc Stock (NWG): Latest News, Forecasts and Analyst Views on 17 December 2025

NatWest Group Plc Stock (NWG): Latest News, Forecasts and Analyst Views on 17 December 2025

NatWest reported continued share buybacks this week, purchasing over 1.6 million shares for cancellation on 15 and 16 December. The bank is also preparing retail trials of “agentic AI” systems, with an announcement expected in early 2026. Regulators are monitoring closely, citing potential risks from rapid, AI-driven market moves. Analyst price targets have tightened after a strong 2025 rally.
17 December 2025
·
UK Stock Market Today (17 December 2025): FTSE 100 Set to Jump as UK Inflation Drops to 3.2% Ahead of Bank of England Rate Decision

UK Stock Market Today (17 December 2025): FTSE 100 Set to Jump as UK Inflation Drops to 3.2% Ahead of Bank of England Rate Decision

UK inflation fell more than expected in November, with headline CPI at 3.2% year-on-year. The FTSE 100 is set to open 0.7% higher, while sterling weakened to around $1.33. Markets now price in a better-than-90% chance the Bank of England will cut rates from 4.00% to 3.75% at Thursday’s meeting.
17 December 2025
···
Rolls-Royce (RR.L) Stock Update 17 December 2025: £200m Buyback, Defence Engine Tests, SMR Momentum and the Latest Analyst Forecasts

Rolls-Royce (RR.L) Stock Update 17 December 2025: £200m Buyback, Defence Engine Tests, SMR Momentum and the Latest Analyst Forecasts

Rolls-Royce announced a £200 million interim share buyback to begin 2 January 2026, following completion of a £1 billion buyback in November. Shares closed at 1,108.5p, up 0.91% on the day, with a market cap near £91.9 billion. The company also started AE 1107 engine testing for the U.S. Army’s MV-75 FLRAA program at its Indianapolis facility.
17 December 2025
·
GSK Stock News Today (Dec. 17, 2025): FDA Approves Twice‑Yearly Asthma Drug Exdensur as Analysts Reassess GSK plc’s 2026 Outlook

GSK Stock News Today (Dec. 17, 2025): FDA Approves Twice‑Yearly Asthma Drug Exdensur as Analysts Reassess GSK plc’s 2026 Outlook

The FDA approved GSK’s Exdensur (depemokimab-ulaa) on Dec. 17 as a twice-yearly add-on treatment for severe eosinophilic asthma in patients 12 and older. Phase III trials showed up to 58% fewer annual asthma exacerbations versus placebo. The FDA declined approval for a second indication, chronic rhinosinusitis with nasal polyps. GSK faces a leadership change Jan. 1, 2026.
17 December 2025
··
1 … 1,128 1,129 1,130 1,131 1,132 … 1,588

Stock Market Updates

Coeur Mining slides after gold, silver drop leaves cash flow target exposed

Coeur Mining slides after gold, silver drop leaves cash flow target exposed

24 June 2026
Coeur Mining plunged 5.1% to $15.47—about $3.4 billion below its recent market cap—as spot gold and silver prices dropped far below the levels used in Coeur’s bullish 2026 guidance, putting its $2 billion free cash flow target and analyst price estimates at risk just days after joining the S&P MidCap 400.
Snap rally puts Specs AR stake close to half its value

Snap rally puts Specs AR stake close to half its value

24 June 2026
Snap has spent over $3.5 billion—about 46% of its $7.5 billion market value—on Specs AR glasses, now facing pressure as Meta launches $299 AI glasses and Snap’s stock remains down 12% since Specs’ June 16 debut, highlighting investor concerns over high costs, slow adoption, and competition.
Transocean falls as oil drop puts offshore drillers under pressure

Transocean falls as oil drop puts offshore drillers under pressure

24 June 2026
Transocean shares plunged 4.5% to $5.04 as oil prices tumbled, raising risks of slower offshore drilling spending despite recent $185 million contract wins and a $7.1 billion backlog; investors remain focused on the $5.8 billion all-stock Valaris merger, now facing U.S. antitrust scrutiny.
Archer drops ahead of Texas decision, FAA testing remains a concern

Archer drops ahead of Texas decision, FAA testing remains a concern

24 June 2026
Archer Aviation shares dropped 3.8% to $5.05 after three straight declines as investors await Friday’s shareholder vote on moving legal incorporation to Texas, while the company advances its Midnight eVTOL aircraft into Phase 4 FAA certification testing amid ongoing cash burn and projected Q2 adjusted EBITDA loss of $170 million to $200 million.
IREN Limited falls on Bitcoin drop and AI spending worries

IREN Limited falls on Bitcoin drop and AI spending worries

24 June 2026
IREN plunged 9.5% to $49.51, underperforming AI and crypto peers, as investors weighed analyst splits on its shift from Bitcoin mining to AI cloud, risks to $4.4 billion revenue targets from chip delivery delays, and a 4.1% drop in Bitcoin, while recent Microsoft and Nvidia deals hinge on meeting strict project timelines.
Go toTop